Editorial and medical review policy

Last updated: August 16, 2026

Where the facts come from

Peptide pages pull live from institutional sources: openFDA (including FAERS and drug labels), ClinicalTrials.gov, PubMed, Europe PMC, DailyMed, bioRxiv and medRxiv, OpenAlex, ChEMBL, UniProt, Open Targets, NIH RePORTER, Semantic Scholar, and CrossRef. Data is cached for one hour, never longer.

We cite primary literature. Where only preclinical or preprint evidence exists, we label it as such on the page rather than presenting it alongside clinical findings.

Evidence is not popularity

Peptide pages show two separate measures. Evidence is derived from published data — the volume and quality of human research supporting a compound. Interest reflects how much attention a compound receives. They are displayed separately and styled differently on purpose, because a widely discussed compound is not the same thing as a well-studied one, and combining the two into a single number would imply a judgement the data does not support.

How we handle unapproved compounds

Many compounds discussed on this site are not approved by the FDA for any use, and several cannot be legally prescribed or compounded in the United States. Those pages carry a status banner at the top stating the regulatory position plainly, including where a compound sits relative to the 503A bulk drug substances list.

We do not present investigational compounds alongside outcome claims. A compound in Phase 3 trials is labelled by its trial status, not by the result people hope it produces. Compounds that cannot be legally compounded are excluded from promotional surfaces on this site, including the trending list on our homepage.

Medical review — current status

We want to be straightforward about this rather than imply a standard we have not yet met. SmartPeptide does not currently have a named clinical reviewer. Library entries and research summaries are written by the SmartPeptide editorial team and sourced from the institutional databases listed above.

We are establishing a formal medical review process with a licensed clinician. When it is in place, every library entry and research summary will carry the reviewer's name, credentials, licensing state, and the date of last review, and this page will be updated to describe the process. Until that happens, no page on this site should be read as having received clinical review.

Corrections

Regulatory status in this area changes quickly. When it does, we update the page and note the change with a date. If you find something wrong, email corrections@smartpeptide.com.

What this site is not

SmartPeptide is an educational research platform. It does not prescribe, diagnose, or treat, and it does not sell peptides. Nothing here is medical advice. Always consult a licensed healthcare provider before using any peptide, supplement, medication, or protocol.